SenzaGen: Order from a global biotech industry leader - Redeye

Redeye endorses SenzaGen’s new order from a global biotech industry leader. We highlight the order value of SEK1.7m and argue it should be considered as high as it is from a new customer. We reiterate our base case of SEK20 and argue the SenzaGen share is currently traded at attractive levels.

Länk till analysen i sin helhet: https://www.redeye.se/research/967412/senzagen-order-from-a-global-biotech-industry-leader?utm_source=finwire&utm_medium=RSS